Skip to main navigation
Skip to search
Skip to main content
Albert Einstein College of Medicine Home
Home
Faculty
Departments
Grants
Publications
Search by expertise, name or affiliation
Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas
AIDS Malignancy Consortium
Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
8
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Ifosfamide
100%
Bortezomib
96%
Carboplatin
88%
Etoposide
84%
Lymphoma
65%
HIV
54%
Safety
45%
Viral Load
32%
Kaposi's Sarcoma
26%
Herpesviridae
25%
Rituximab
24%
Human Herpesvirus 4
22%
Cytidine Deaminase
16%
Maximum Tolerated Dose
13%
Viremia
12%
Survival
12%
Proteasome Endopeptidase Complex
11%
Antiviral Agents
9%
Infections
5%
Therapeutics
3%